HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.063x

Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see HPGC Renmintongtai Pharmaceutical Corp (600829) market capitalisation for the company's overall valuation and market capitalisation.

HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency. Explore HPGC Renmintongtai Pharmaceutical Corp cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Pexa Group Ltd AU:PXA	0.066x
Camden National Corporation NASDAQ:CAC	0.028x
Xianheng International Science & Technology Co Ltd SHG:605056	N/A
JM AB (publ) ST:JM	-0.005x
TeamViewer AG F:TMV	0.803x
CHINA RISUN GROUP HD-10 F:45Y	N/A
Power HF Co Ltd SHG:605100	0.060x
Summit TA:SMT	0.016x

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. View HPGC Renmintongtai Pharmaceutical Corp (600829) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.01 Billion ≈ $441.19 Million	CN¥299.98 Million ≈ $43.90 Million	0.099x	+148.33%
2024-12-31	CN¥2.88 Billion ≈ $421.60 Million	CN¥115.44 Million ≈ $16.89 Million	0.040x	-66.89%
2023-12-31	CN¥2.75 Billion ≈ $402.61 Million	CN¥332.99 Million ≈ $48.73 Million	0.121x	-3.02%
2022-12-31	CN¥2.46 Billion ≈ $360.36 Million	CN¥307.33 Million ≈ $44.97 Million	0.125x	+217.79%
2021-12-31	CN¥2.20 Billion ≈ $321.82 Million	CN¥-233.00 Million ≈ $-34.10 Million	-0.106x	-2188.91%
2020-12-31	CN¥1.99 Billion ≈ $291.54 Million	CN¥-9.22 Million ≈ $-1.35 Million	-0.005x	+97.92%
2019-12-31	CN¥1.85 Billion ≈ $270.31 Million	CN¥-411.60 Million ≈ $-60.23 Million	-0.223x	-196.07%
2018-12-31	CN¥1.58 Billion ≈ $231.19 Million	CN¥366.45 Million ≈ $53.62 Million	0.232x	+168.84%
2017-12-31	CN¥1.61 Billion ≈ $235.89 Million	CN¥139.07 Million ≈ $20.35 Million	0.086x	+208.97%
2016-12-31	CN¥1.65 Billion ≈ $241.12 Million	CN¥46.01 Million ≈ $6.73 Million	0.028x	-88.10%
2015-12-31	CN¥1.42 Billion ≈ $208.27 Million	CN¥333.99 Million ≈ $48.87 Million	0.235x	+28.70%
2014-12-31	CN¥2.15 Billion ≈ $315.05 Million	CN¥392.58 Million ≈ $57.45 Million	0.182x	+360.00%
2013-12-31	CN¥2.26 Billion ≈ $330.33 Million	CN¥-158.31 Million ≈ $-23.17 Million	-0.070x	-172.98%
2012-12-31	CN¥2.31 Billion ≈ $337.41 Million	CN¥221.57 Million ≈ $32.42 Million	0.096x	+271.75%
2011-12-31	CN¥1.94 Billion ≈ $283.25 Million	CN¥-108.30 Million ≈ $-15.85 Million	-0.056x	-159.69%
2010-12-31	CN¥1.74 Billion ≈ $254.43 Million	CN¥162.99 Million ≈ $23.85 Million	0.094x	-65.32%
2009-12-31	CN¥1.66 Billion ≈ $242.41 Million	CN¥447.82 Million ≈ $65.53 Million	0.270x	+776.00%
2008-12-31	CN¥1.65 Billion ≈ $241.27 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.040x	-129.42%
2007-12-31	CN¥1.41 Billion ≈ $205.71 Million	CN¥191.10 Million ≈ $27.96 Million	0.136x	-22.95%
2006-12-31	CN¥1.08 Billion ≈ $158.53 Million	CN¥191.13 Million ≈ $27.97 Million	0.176x	-49.94%
2005-12-31	CN¥888.23 Million ≈ $129.98 Million	CN¥313.04 Million ≈ $45.81 Million	0.352x	+504.14%
2004-12-31	CN¥1.04 Billion ≈ $152.24 Million	CN¥60.69 Million ≈ $8.88 Million	0.058x	-54.38%
2003-12-31	CN¥560.39 Million ≈ $82.00 Million	CN¥71.65 Million ≈ $10.48 Million	0.128x	-47.23%
2002-12-31	CN¥526.17 Million ≈ $77.00 Million	CN¥127.49 Million ≈ $18.66 Million	0.242x	+720.86%
2001-12-31	CN¥501.11 Million ≈ $73.33 Million	CN¥14.79 Million ≈ $2.16 Million	0.030x	-77.75%
2000-12-31	CN¥466.36 Million ≈ $68.24 Million	CN¥61.85 Million ≈ $9.05 Million	0.133x	-3.81%
1999-12-31	CN¥422.13 Million ≈ $61.77 Million	CN¥58.21 Million ≈ $8.52 Million	0.138x	+44.85%
1998-12-31	CN¥430.69 Million ≈ $63.02 Million	CN¥41.00 Million ≈ $6.00 Million	0.095x	--

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic

Market Cap

$857.04 Million

CN¥5.86 Billion CNY

Market Cap Rank

#9714 Global

#2530 in China

Share Price

CN¥10.10

Change (1 day)

+0.20%

52-Week Range

CN¥7.76 - CN¥17.72

All Time High

CN¥17.72